To determine the oncogenic effects of MKRN1-mediated inhibition of the PTEN tumour suppressor and activation of the PI3K/AKT pathway, we conducted a transwell migration assay using human cervical cancer cell lines (HeLa, ME-180 and CaSki). This evidence concerns the gene PTEN and cervical carcinoma.